Page 171 - 南京医科大学学报自然科学版
P. 171
第41卷第7期 林 欢,冯旰珠. 冠状病毒Spike蛋白及其针对性治疗研究进展[J].
2021年7月 南京医科大学学报(自然科学版),2021,41(07):1095-1103 ·1101 ·
ing antibodies against the novel coronavirus SARS⁃CoV⁃2 favors ACE2 from bovidae and cricetidae[J]. J Med Vi⁃
[J]. Int J Biol Sci,2020,16(10):1718-1723 rol,2020,92(9):1649-1656
[2] JIANG S B,DU L Y,SHI Z L. An emerging coronavirus [16] ALSAADI E J,NEUMAN B W,JONES I M. A fusion pep⁃
causing pneumonia outbreak in Wuhan,China:calling for tide in the spike protein of MERS coronavirus[J]. Virus⁃
developing therapeutic and prophylactic strategies[J]. es,2019,11(9):825
Emerg Microbes Infect,2020,9(1):275-277 [17] SHANG J,WAN Y,LUO C,et al. Cell entry mechanisms
[3] LAN J,GE J W,YU J,et al. Structure of the SARS⁃CoV⁃2 of SARS⁃CoV⁃2[J]. Proc Natl Acad Sci USA,2020,117
spike receptor⁃binding domain bound to the ACE2 recep⁃ (21):11727-11734
tor[J]. Nature,2020,581(787):215-220 [18] STERNBERG A,NAUJOKAT C. Structural features of
[4] HOFFMANN M,KLEINE⁃WEBER H,SCHROEDER S, coronavirus SARS⁃CoV⁃2 spike protein:targets for vacci⁃
et al. SARS⁃CoV⁃2 cell entry depends on ACE2 and TM⁃ nation[J]. Life Sci,2020,257:118056
PRSS2 and is blocked by a clinically proven protease in⁃ [19] BANGARU S,OZOROWSKI G,TURNER H L,et al.
hibitor[J]. Cell,2020,181(2):271-280 Structural analysis of full⁃length SARS⁃CoV⁃2 spike pro⁃
[5] HUANG Y,YANG C,XU X F,et al. Structural and func⁃ tein from an advanced vaccine candidate[J]. Science,
tional properties of SARS⁃CoV⁃2 spike protein:potential 2020,370(6520):1089-1094
antivirus drug development for COVID⁃19[J]. Acta Phar⁃ [20] MERCURIO I,TRAGNI V,BUSTO F,et al. Protein struc⁃
macolSin,2020,41(9):1141-1149 ture analysis of the interactions between SARS ⁃ CoV ⁃ 2
[6] WALLS A C,PARK Y J,TORTORICI M A,et al. Struc⁃ spike protein and the human ACE2 receptor:from confor⁃
ture,function,and antigenicity of the SARS⁃CoV⁃2 spike mational changes to novel neutralizing antibodies[J].
glycoprotein[J]. Cell,2020,181(2):281-292 Cell Mol Life Sci,2021,78(4):1501-1522
[7] CAI Y,ZHANG J,XIAO T,et al. Distinct conformational [21] PILLAY T S. Gene of the month:the 2019⁃nCoV/SARS⁃
states of SARS⁃CoV⁃2 spike protein[J]. Science,2020, CoV⁃2 novel coronavirus spike protein[J]. J Clin Pathol,
369(6511):1586-1592 2020,73(7):366-369
[8] LU M,UCHIL P D,LI W,et al. Real⁃Time conformational [22] BARNES C O,JETTE C A,ABERNATHY M E,et al.
dynamics of SARS⁃CoV⁃2 spikes on virus particles[J]. SARS⁃CoV⁃2 neutralizing antibody structures inform ther⁃
Cell Host Microbe,2020,28(6):880-891 apeutic strategies[J]. Nature,2020,588(7839):682-687
[9] SONG W,GUI M,WANG X Q,et al. Cryo⁃EM structure [23] KLEINE ⁃ WEBER H,ELZAYAT M T,WANG L,et al.
of the SARS coronavirus spike glycoprotein in complex Mutations in the spike protein of Middle East respiratory
with its host cell receptor ACE2[J]. PLoS Pathog,2018, syndrome coronavirus transmitted in Korea increase resis⁃
14(8):e1007236 tance to antibody ⁃ mediated neutralization[J]. J Virol,
[10] WANG Q,ZHANG Y,WU L,et al. Structural and func⁃ 2019,93(2):e01318-e01381
tional basis of SARS⁃CoV⁃2 entry by using human ACE2 [24] LI Y,WAN Y,LIU P,et al. A humanized neutralizing an⁃
[J]. Cell,2020,181(4):894-904 tibody against MERS⁃CoV targeting the receptor⁃binding
[11] YAN R,ZHANG Y,LI Y,et al. Structural basis for the domain of the spike protein[J]. Cell Res,2015,25(11):
recognition of SARS⁃CoV⁃2 by full⁃length human ACE2 1237-1249
[J]. Science,2020,367(6485):1444-1448 [25] HAN H J,LIU J W,YU H,et al. Neutralizing monoclonal
[12] CHI X,YAN R,ZHANG J,et al. A neutralizing human an⁃ antibodies as promising therapeutics against Middle East
tibody binds to the N⁃terminal domain of the Spike pro⁃ respiratory syndrome coronavirus infection[J]. Viruses,
tein of SARS⁃CoV⁃2[J]. Science,2020,369(654):650- 2018,10(12):680
655 [26] WAN Y,SHANG J,SUN S,et al. Molecular mechanism
[13] HUSSAIN M,JABEEN N,RAZA F,et al. Structural varia⁃ for antibody⁃dependent enhancement of coronavirus entry
tions in human ACE2 may influence its binding with [J]. J Virol,2020,94(5):e02015⁃e02019
SARS ⁃ CoV ⁃ 2 spike protein[J]. J Med Virol,2020,92 [27] XU J,JIA W,WANG P,et al. Antibodies and vaccines
(9):1580-1586 against Middle East respiratory syndrome coronavirus[J].
[14] LUAN J,LU Y,JIN X,et al. Spike protein recognition of Emerg Microbes Infect,2019,8(1):841⁃856
mammalian ACE2 predicts the host range and an opti⁃ [28] SUI J,LI W,MURAKAMI A,et al. Potent neutralization
mized ACE2 for SARS⁃CoV⁃2 infection[J]. BiochemBio⁃ of severe acute respiratory syndrome(SARS)coronavirus
phys Res Commun,2020,526(1):165-169 by a human mAb to S1 protein that blocks receptor associ⁃
[15] LUAN J,JIN X,LU Y,et al. SARS⁃CoV⁃2 spike protein ation[J]. Proc Natl Acad Sci USA,2004,101(8):2536-